# Korro Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/korro-bio

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.korrobio.com
- Total disclosed funding: $208M
- Latest round: Series B (Jan 5, 2022)
- Investors on record: 15

## About

Founded in 2018 by co-founders Andrew Fraley and Nessan Bermingham and based in Massachusetts, US, Korro Bio, Inc. develops genetic therapeutics through targeted RNA editing. In April 2024, Korro Bio, Inc. raised USD 70 million in PIPE funding led by investor Deep Track Capital, with participation from other investors Rock Springs Capital, Tri Locum Partners, Blue Owl Capital, Atlas Venture, and New Enterprise Associates. As of April 2024, the company is led by CEO Ram A. Iyar.

The company's products are in the research and development phase, focusing on utilizing Oligonucleotide Promoted Editing of RNA (OPERA) to create new RNA-based therapies for patients with debilitating and life-threatening illnesses.

The company will use the April 2024 funding for the development of its new genetic medicines, working capital, and general corporate purposes.

## Funding rounds

- Series B, Jan 5, 2022, $116M — Atlas Venture, New Enterprise Associates, Alexandria Venture Investments, Qiming Venture Partners, Invus [DUP], Fidelity Investments, Surveyor Capital, MP Healthcare Venture Management, Verition Fund Management, Cormorant Asset Management, Monashee Investment Management, Wu Capital, Eventide Asset Management, Point72 Asset Management, Sixty Degree Capital
- Series A, Sep 10, 2020, $92M — Atlas Venture, New Enterprise Associates, Alexandria Venture Investments, Qiming Venture Partners, Surveyor Capital, MP Healthcare Venture Management, Cormorant Asset Management, Wu Capital

## Investors

- Atlas Venture (https://capitalatlas.ai/funds/atlas-venture) — Series A, Series B
- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series A, Series B
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series A, Series B
- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series A, Series B
- Surveyor Capital — Series A, Series B
- MP Healthcare Venture Management (https://capitalatlas.ai/funds/mp-healthcare-venture-management) — Series A, Series B
- Cormorant Asset Management (https://capitalatlas.ai/funds/cormorant-asset-management) — Series A, Series B
- Wu Capital — Series A, Series B
- Invus [DUP] — Series B
- Fidelity Investments (https://capitalatlas.ai/funds/fidelity-investments) — Series B
- Verition Fund Management — Series B
- Monashee Investment Management — Series B
- Eventide Asset Management (https://capitalatlas.ai/funds/eventide-asset-management) — Series B
- Point72 Asset Management — Series B
- Sixty Degree Capital (https://capitalatlas.ai/funds/sixty-degree-capital) — Series B